COVID-19 Vaccine by Pfizer and Biontech achieves first Emergency Use Authorization in the world after UK approves it for widespread use
Pfizer Inc. and BioNTech SE announced today that the Medicines & Healthcare Products Regulatory Agency (MHRA) in the U.K. has granted a temporary authorization for emergency use for their COVID-19 vaccine against COVID-19. The authorization comes following a worldwide Phase 3 trial of a vaccine. In a press release, Pfizer and BioNTech have said that they are anticipating further regulatory decisions across the globe in the coming days and weeks and are ready to deliver vaccine doses following potential regulatory authorizations or approvals.
The UK government has said that the distribution of the vaccine in the country will be prioritized according to the populations identified in guidance from the Joint Committee on Vaccination and Immunisation (JCVI).
“Today’s...